Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 317

    3.

    Nitric oxide stimulates glucose transport through insulin-independent GLUT4 translocation in 3T3-L1 adipocytes.

    Tanaka T, Nakatani K, Morioka K, Urakawa H, Maruyama N, Kitagawa N, Katsuki A, Araki-Sasaki R, Hori Y, Gabazza EC, Yano Y, Wada H, Nobori T, Sumida Y, Adachi Y.

    Eur J Endocrinol. 2003 Jul;149(1):61-7.PMID: 12824867 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Inhibition of insulin sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3-L1 adipocytes.

    Gao Z, Zhang X, Zuberi A, Hwang D, Quon MJ, Lefevre M, Ye J.

    Mol Endocrinol. 2004 Aug;18(8):2024-34. Epub 2004 May 13.PMID: 15143153 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Bradykinin enhances GLUT4 translocation through the increase of insulin receptor tyrosine kinase in primary adipocytes: evidence that bradykinin stimulates the insulin signalling pathway.

    Isami S, Kishikawa H, Araki E, Uehara M, Kaneko K, Shirotani T, Todaka M, Ura S, Motoyoshi S, Matsumoto K, Miyamura N, Shichiri M.

    Diabetologia. 1996 Apr;39(4):412-20.PMID: 8777990 [PubMed - indexed for MEDLINE]Related articles

    7.

    Mechanism of feedback regulation of insulin receptor substrate-1 phosphorylation in primary adipocytes.

    Hers I, Tavaré JM.

    Biochem J. 2005 Jun 1;388(Pt 2):713-20.PMID: 15713122 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Enhanced basal activation of mitogen-activated protein kinases in adipocytes from type 2 diabetes: potential role of p38 in the downregulation of GLUT4 expression.

    Carlson CJ, Koterski S, Sciotti RJ, Poccard GB, Rondinone CM.

    Diabetes. 2003 Mar;52(3):634-41.PMID: 12606502 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    ERK1/2 activation by angiotensin II inhibits insulin-induced glucose uptake in vascular smooth muscle cells.

    Izawa Y, Yoshizumi M, Fujita Y, Ali N, Kanematsu Y, Ishizawa K, Tsuchiya K, Obata T, Ebina Y, Tomita S, Tamaki T.

    Exp Cell Res. 2005 Aug 15;308(2):291-9.PMID: 15921682 [PubMed - indexed for MEDLINE]Related articles

    10.

    Pancreastatin modulates insulin signaling in rat adipocytes: mechanisms of cross-talk.

    González-Yanes C, Sánchez-Margalet V.

    Diabetes. 2000 Aug;49(8):1288-94.PMID: 10923627 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    C-reactive protein induces phosphorylation of insulin receptor substrate-1 on Ser307 and Ser 612 in L6 myocytes, thereby impairing the insulin signalling pathway that promotes glucose transport.

    D'Alessandris C, Lauro R, Presta I, Sesti G.

    Diabetologia. 2007 Apr;50(4):840-9. Epub 2007 Feb 6.PMID: 17279354 [PubMed - indexed for MEDLINE]Related articles

    12.

    C-reactive protein suppresses insulin signaling in endothelial cells: role of spleen tyrosine kinase.

    Xu JW, Morita I, Ikeda K, Miki T, Yamori Y.

    Mol Endocrinol. 2007 Feb;21(2):564-73. Epub 2006 Nov 9.PMID: 17095576 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Bradykinin potentiates insulin-stimulated glucose uptake and enhances insulin signal through the bradykinin B2 receptor in dog skeletal muscle and rat L6 myoblasts.

    Miyata T, Taguchi T, Uehara M, Isami S, Kishikawa H, Kaneko K, Araki E, Shichiri M.

    Eur J Endocrinol. 1998 Mar;138(3):344-52.PMID: 9539311 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Bradykinin enhances insulin receptor tyrosine kinase in 32D cells reconstituted with bradykinin and insulin signaling pathways.

    Motoshima H, Araki E, Nishiyama T, Taguchi T, Kaneko K, Hirashima Y, Yoshizato K, Shirakami A, Sakai K, Kawashima J, Shirotani T, Kishikawa H, Shichiri M.

    Diabetes Res Clin Pract. 2000 Jun;48(3):155-70.PMID: 10802154 [PubMed - indexed for MEDLINE]Related articles

    16.

    c-Jun N-terminal kinase 1/2 activation by tumor necrosis factor-alpha induces insulin resistance in human visceral but not subcutaneous adipocytes: reversal by liver X receptor agonists.

    Fernández-Veledo S, Vila-Bedmar R, Nieto-Vazquez I, Lorenzo M.

    J Clin Endocrinol Metab. 2009 Sep;94(9):3583-93. Epub 2009 Jun 30.PMID: 19567513 [PubMed - indexed for MEDLINE]Related articles

    17.

    Enhancement of muscle glucose uptake by the vasopeptidase inhibitor, omapatrilat, is independent of insulin signaling and the AMP kinase pathway.

    Wong V, Szeto L, Uffelman K, Fantus IG, Lewis GF.

    J Endocrinol. 2006 Aug;190(2):441-50.PMID: 16899577 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Interleukin-6 impairs the insulin signaling pathway, promoting production of nitric oxide in human umbilical vein endothelial cells.

    Andreozzi F, Laratta E, Procopio C, Hribal ML, Sciacqua A, Perticone M, Miele C, Perticone F, Sesti G.

    Mol Cell Biol. 2007 Mar;27(6):2372-83. Epub 2007 Jan 22.PMID: 17242212 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Role of IRS-3 in the insulin signaling of IRS-1-deficient brown adipocytes.

    Arribas M, Valverde AM, Benito M.

    J Biol Chem. 2003 Nov 14;278(46):45189-99. Epub 2003 Aug 27.PMID: 12944402 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Sequential phosphorylation of insulin receptor substrate-2 by glycogen synthase kinase-3 and c-Jun NH2-terminal kinase plays a role in hepatic insulin signaling.

    Sharfi H, Eldar-Finkelman H.

    Am J Physiol Endocrinol Metab. 2008 Feb;294(2):E307-15. Epub 2007 Nov 20.PMID: 18029441 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data